Designates March of each year as "Fibromuscular Dysplasia Awareness Month."
Impact
The resolution's designation as an awareness month is significant as it seeks to address the under-recognition of FMD, which predominantly affects women yet remains poorly understood within the medical community. Its push for awareness will aid patients and their families who often face isolation and difficulties in securing timely diagnosis and treatment. FMD has been classified as a rare disease, and it is estimated that about four to five percent of the population may be affected. Consequently, this resolution promotes a public health issue that necessitates further research and understanding.
Summary
AJR115 is a joint resolution aimed at designating March of each year as 'Fibromuscular Dysplasia Awareness Month' in the state of New Jersey. This resolution recognizes the need for increased understanding and awareness of Fibromuscular Dysplasia (FMD), a rare disease characterized by abnormal cell growth in the arterial walls which can result in serious health complications. Given that there has been a longstanding lack of awareness surrounding this condition, the resolution aims to foster recognition among both the public and healthcare professionals about the disease and its implications.
Contention
While the resolution may seem non-controversial at first glance, the actual impact of such designations can lead to discussions about state health initiatives, funding for awareness campaigns, and the role of government in promoting lesser-known health issues. Critics may argue about the allocation of resources, questioning whether the focus on a specific rare disease might detract attention from other pressing health concerns. Nonetheless, supporters suggest that raising awareness for FMD could ultimately lead to better outcomes for patients and a greater understanding within the medical field, possibly paving the way for future research funding and treatment protocols.